Alcohol Septal Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
Authors:
- Sherif F. NaguehSNSherif F. Nagueh
- John M. BuerglerJBJohn M. Buergler
- Steven K. RoweSRSteven K. Rowe
- Yolanda Munoz MaldonadoYMYolanda Munoz Maldonado
- 1 November 2011
- Vol. 58 (22) , 2322-2328
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve LeafletsCirculation, 2005
- Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity scoreThe Journal of Thoracic and Cardiovascular Surgery, 2005
- American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic CardiomyopathyJACC, 2003
- Effect of Left Ventricular Outflow Tract Obstruction on Clinical Outcome in Hypertrophic CardiomyopathyNew England Journal of Medicine, 2003
- Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomesEuropean Heart Journal, 2002
- Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathyJACC, 2001
- Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patientsHeart, 2000
- Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathyEuropean Heart Journal, 1999
- Nonsurgical Septal Reduction for Hypertrophic Obstructive CardiomyopathyCirculation, 1997
- Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathyThe Lancet, 1995